Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
揭開層面：通過分析師見解探索Marinus Pharma
Throughout the last three months, 4 analysts have evaluated Marinus Pharma (NASDAQ:MRNS), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，有4位分析師對Marinus Pharma（納斯達克股票代碼：MRNS）進行了評估，提出了從看漲到看跌的不同觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $21.75, with a high estimate of $27.00 and a low estimate of $9.00. Observing a 141.67% increase, the current average has risen from the previous average price target of $9.00.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲21.75美元，最高估計爲27.00美元，低估值爲9.00美元。目前的平均價格上漲了141.67％，已從之前的平均目標價9.00美元上漲。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The standing of Marinus Pharma among financial experts...
通過對分析師近期...
登入免費觀看全文
登入/註冊